Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Scrip

Coronavirus Update: US Adds To Antibody Push With $486m AstraZeneca Deal

After a week of monoclonal antibody therapies hitting the headlines - including a personal endorsement from President Trump - the US government bulks up its potential supplies. AZ's long-acting monoclonal antibody product enters large-scale trials for both a treatment and prophylaxis of COVID-19.

Topic Coronavirus

View article
Scrip

J&J Says It's Wait And See On COVID-19 Vaccine Delay Outlines Rosier Outlook for 2021

It will be several days at least before more information is available about the unexpected illness in J&J's Phase III COVID-19 vaccine trial, the firm said during its third quarter financial call.

Topic Coronavirus Vaccines Clinical Trials

View article
Citeline

Clinical Trials & the COVID-19 Vaccine

Informa Pharma Intelligence’s Pulse Report

Topic Coronavirus Clinical Trials

Single report
HBW Insight, Generics Bulletin, Medtech Insight, Datamonitor...

Pharma Intelligence Launches Alexa Skill

Keep up with topics you care about in Pharma and Medtech with the new Alexa Skill from Informa Pharma Intelligence. Access daily news briefings to stay up to date with the latest news, right from your Alexa smartphone app!

Topic Artificial Intelligence Consumer Innovation

View article
Scrip, Datamonitor Healthcare

Top 10 Best-Selling Drugs of 2019

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic Drug Review Diseases

Single report
Citeline

The New Normal for Clinical Trials and Planning for the Future Webinar

Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.

Topic Clinical Trials

Full webinar
Citeline

Rare Congenital and Genetic Diseases Strategy Solutions

Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes.

Topic Diseases

View white paper
Medtech Insight

Cancer Research UK: Early Diagnosis And Disease Detection Must Not Be Eclipsed By COVID-19

Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.

Topic Cancer Policy & Regulation

View article
Medtech Insight

87636 And 87637: New CPT Codes From AMA For COVID-19/Flu Combo Antigen Tests

The American Medical Association has added two new Current Procedural Terminology (CPT) codes for reporting antigen tests that detect COVID-19 and influenza. And a third new code, 87811, should be used to report “infectious agent antigen detection by immunoassay with direct visual observation.”

Topic Coronavirus

View article
Scrip

Quick Listen: Scrip's Five Must-Know Things

Join us for an audio roundup of major events in the international biopharma industry over the past week, as reported by Scrip's global team

Topic Coronavirus Clinical Trials

Full podcast
Scrip

Vir/GSK Move Lead Coronavirus Antibody Into Phase III

Results from a Phase II/III study for VIR-7831 in the prevention of hospitalization due to COVID-19 are expected in late 2020 and early 2021.

Topic Coronavirus Research & Development

View article
Pink Sheet, Scrip

Executive Privilege: How Giving Trump Special Access To Experimental COVID Treatment Could Backfire

Trump receives Regeneron’s experimental antibody under FDA’s expanded access program, Gilead’s remdesivir and dexamethasone. The president’s treatment choices could influence clinical trials of all COVID-19 medicines and even trial recruitment for other diseases, experts said.

Topic Coronavirus US Election 2020 Clinical Trials

View article
Pink Sheet

US Election 2020: Trump's Sway Over Courts Expected To Linger

Textualist judges appointed by President Trump during his term may block a potential President Biden’s attempts to shift the government’s legal policies.

Topic US Election 2020 Policy & Regulation

View article
Pink Sheet

VP Debate: Pence Tries Vaccine Hesitancy Jujutsu On Harris

‘Senator, please stop undermining confidence in a vaccine,’ Pence says when confronted with the accusation that the administration is politicizing the COVID vaccine development effort.

Topic Coronavirus Vaccines US Election 2020

View article
Pink Sheet

EU Pharma Strategy To Balance Innovation Incentives and Competition

Delegates at this week’s TOPRA conference heard the European Commission’s “holistic” vision of what it would like to achieve through its pharmaceutical strategy, including incentives for innovation, security of the supply chain, product shortages, real world evidence and big data, and the availability and affordability of medicines.

Topic EU Artificial Intelligence Regulation

View article

Latest headlines

Medtech Insight

20 Oct 2020

Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India

Link
Pink Sheet

20 Oct 2020

What Came Before COVID-19: Two Centuries Of Vaccine Development

Link
Pink Sheet

20 Oct 2020

US FDA Needs To Harmonize Postmarket Safety Plans For COVID Vaccines, CDC Advisors Urge

Link
Pink Sheet

20 Oct 2020

COVID Vaccine Postmarket Monitoring Will Depend On Which Adverse Events US FDA Wants To Watch

Link
Pink Sheet

20 Oct 2020

Emer Cooke Prepares To Take Over As Head Of EMA

Link
Generics Bulletin

20 Oct 2020

H2 Pharma Offloads Minority Interest To Private Equity

Link
Scrip

20 Oct 2020

Aptinyx To Forge Ahead With Pivotal PTSD Study

Link
HBW Insight

20 Oct 2020

P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

Link
Scrip

20 Oct 2020

Coronavirus Update: Human Vaccine Challenge Study Gains UK Backing

Link
Scrip

20 Oct 2020

Stockwatch: Pandemic And Biosimilar Effects Subordinate Early Third-Quarter Earnings Results

Link
HBW Insight

20 Oct 2020

Bayer Steps Up Skin Microbiome Research For Cosmetics With Partner Azitra

Link
Scrip

20 Oct 2020

Asia Deal Watch: Rhizen Licenses Chinese Rights For PI3K Inhibitor To Curon

Link
Medtech Insight

20 Oct 2020

HLTH 2020: Panel Finds Pandemic Accelerates Uses For Robots In Health Care, Even ‘Zumba’

Link
Medtech Insight

20 Oct 2020

Boston Scientific's TAVR Pipeline Delayed; FDA Approval Of Acurate neo2 Set For 2024

Link
Medtech Insight

20 Oct 2020

Step-By-Step How To Register In Eudamed By December Start Date: Commission Explains

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Coronavirus Update: US Adds To Antibody Push With $486m AstraZeneca Deal

J&J Says It's Wait And See On COVID-19 Vaccine Delay Outlines Rosier Outlook for 2021

Clinical Trials & the COVID-19 Vaccine

Pharma Intelligence Launches Alexa Skill

Top 10 Best-Selling Drugs of 2019

The New Normal for Clinical Trials and Planning for the Future Webinar

Rare Congenital and Genetic Diseases Strategy Solutions

Cancer Research UK: Early Diagnosis And Disease Detection Must Not Be Eclipsed By COVID-19

87636 And 87637: New CPT Codes From AMA For COVID-19/Flu Combo Antigen Tests

Quick Listen: Scrip's Five Must-Know Things

Vir/GSK Move Lead Coronavirus Antibody Into Phase III

Executive Privilege: How Giving Trump Special Access To Experimental COVID Treatment Could Backfire

US Election 2020: Trump's Sway Over Courts Expected To Linger

VP Debate: Pence Tries Vaccine Hesitancy Jujutsu On Harris

EU Pharma Strategy To Balance Innovation Incentives and Competition

Latest headlines

Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India

What Came Before COVID-19: Two Centuries Of Vaccine Development

US FDA Needs To Harmonize Postmarket Safety Plans For COVID Vaccines, CDC Advisors Urge

COVID Vaccine Postmarket Monitoring Will Depend On Which Adverse Events US FDA Wants To Watch

Emer Cooke Prepares To Take Over As Head Of EMA

H2 Pharma Offloads Minority Interest To Private Equity

Aptinyx To Forge Ahead With Pivotal PTSD Study

P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

Coronavirus Update: Human Vaccine Challenge Study Gains UK Backing

Stockwatch: Pandemic And Biosimilar Effects Subordinate Early Third-Quarter Earnings Results

Bayer Steps Up Skin Microbiome Research For Cosmetics With Partner Azitra

Asia Deal Watch: Rhizen Licenses Chinese Rights For PI3K Inhibitor To Curon

HLTH 2020: Panel Finds Pandemic Accelerates Uses For Robots In Health Care, Even ‘Zumba’

Boston Scientific's TAVR Pipeline Delayed; FDA Approval Of Acurate neo2 Set For 2024

Step-By-Step How To Register In Eudamed By December Start Date: Commission Explains

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store